Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts.
Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.
- ArriVent BioPharma (AVBP) – ArriVent BioPharma is a clinical-stage drug developer working on new targeted cancer medicines for hard-to-treat tumors. Today, BTIG analyst Justin Zelin maintained a Buy rating on the stock with a price target of $275 per share. In the last three months, all three Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 45.85%.
- Amazon (AMZN) – Amazon is a global tech and retail giant that runs the world’s largest online marketplace and a leading cloud business through AWS. Today, TD Cowen analyst John Blackledge maintained a Buy rating on the stock with a price target of $300 per share. In the last three months, all 42 Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 30.24%.
- Apogee Therapeutics (APGE) – This is a clinical-stage biotech company developing antibody treatments for inflammatory and immune-related diseases. Today, Deutsche Bank analyst David Hoang maintained a Buy rating on the stock with a price target of $103 per share. In the last three months, all eight Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 25.96%.
Who Are the Top Analysts?
TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time.
See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page.